CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-11 | Reilly Joseph H. SVP & Chief Operating Officer | Sale | −1,600 | $12.03 | $19K | 8,333 |
| 2017-01-11 | Reilly Joseph H. SVP & Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −1,600 | 67,400 | ||
| 2017-01-04 | Levine Mark S. SVP,General Counsel & Sec. | Option exercise | +17,250 | $4.71 | $81K | 17,250 |
| 2017-01-04 | Levine Mark S. SVP,General Counsel & Sec. | Option exercise | +250 | $5.19 | $1K | 17,500 |
| 2017-01-04 | Levine Mark S. SVP,General Counsel & Sec. | Sale | −17,500 | $12.00 | $210K | 0 |
| 2017-01-04 | Levine Mark S. SVP,General Counsel & Sec. | Option exercise · Stock Option (Right to Buy) | −17,250 | 51,750 | ||
| 2017-01-04 | Levine Mark S. SVP,General Counsel & Sec. | Option exercise · Stock Option (Right to Buy) | −250 | 57,274 | ||
| 2017-01-03 | Davidson Michael Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +145,000 | 145,000 | ||
| 2016-12-27 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise | +12,000 | $4.71 | $57K | 22,000 |
| 2016-12-27 | Ahlholm Frederick W SVP, Chief Accounting Officer | Sale | −17,000 | $12.51 | $213K | 5,000 |
| 2016-12-27 | Ahlholm Frederick W SVP, Chief Accounting Officer | Option exercise · Employee Stock Option (Right to Buy) | −12,000 | 57,000 | ||
| 2016-12-14 | Luthringer Remy President & CEO | Grant or award · Restricted Stock Unit | +75,000 | 75,000 | ||
| 2016-12-14 | Luthringer Remy President & CEO | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2016-12-14 | Race Geoff EVP, CFO & Chief Business Off. | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2016-12-14 | Race Geoff EVP, CFO & Chief Business Off. | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2016-12-14 | Reilly Joseph H. SVP & Chief Operating Officer | Grant or award · Restricted Stock Unit | +35,000 | 35,000 | ||
| 2016-12-14 | Reilly Joseph H. SVP & Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2016-12-14 | Levine Mark S. SVP,General Counsel & Sec. | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2016-12-14 | Levine Mark S. SVP,General Counsel & Sec. | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2016-12-14 | Ahlholm Frederick W SVP, Chief Accounting Officer | Grant or award · Restricted Stock Unit | +20,000 | 20,000 |
Page 14 of 16 · 305 trades